Technical Analysis for AVH - Avita Medical Ltd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
0.585 | 8.33% | 0.045 |
AVH closed unchanged on Thursday, December 12, 2019, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| See historical AVH trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 8.33% | |
| NR7 | Range Contraction | 8.33% | |
| Stochastic Reached Oversold | Weakness | 8.33% | |
| Inside Day | Range Contraction | 8.33% | |
| Oversold Stochastic | Weakness | 8.33% | |
| Down 3 Days in a Row | Weakness | 8.33% | |
| Gapped Down | Weakness | 7.34% | |
| 50 DMA Resistance | Bearish | 2.63% | |
| Fell Below 20 DMA | Bearish | 2.63% | |
| MACD Bearish Signal Line Cross | Bearish | 2.63% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
- Sector: Healthcare
- Industry: Medical Devices
Avita Medical Limited is a medical technology company. The principal activities of the Company are the commercialization of its regenerative product. The Company has three segments: the Asia Pacific region; the Americas, including Canada, and the Europe, Middle East and Africa (EMEA) region. It develops and distributes regenerative products for the treatment of a range of wounds, scars and skin defects. Its collection and application technology provides treatment solutions derived from the regenerative properties of a patient's own skin. The Company's product, ReCell, is used in the treatment of a range of burns, plastic, reconstructive and cosmetic procedures. Its technology, Regenerative Epithelial Suspension (RES), is an autologous suspension composed of the cells and wound-healing factors necessary to regenerate natural skin. The Company also offers ReGenerCell, which is used for the treatment of wounds, and ReNovaCell, which is used for the treatment of pigmentation.
Health Medical Technology Burns Scar Treatment Solutions
Health Medical Technology Burns Scar Treatment Solutions
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.74 |
| 52 Week Low | 0.077 |
| Average Volume | 14,759,292 |
| 200-Day Moving Average | 0.447 |
| 50-Day Moving Average | 0.606 |
| 20-Day Moving Average | 0.579 |
| 10-Day Moving Average | 0.581 |
| Average True Range | 0.039 |
| ADX | 14.07 |
| +DI | 19.417 |
| -DI | 30.463 |
| Chandelier Exit (Long, 3 ATRs ) | 0.539 |
| Chandelier Exit (Short, 3 ATRs ) | 0.621 |
| Upper Bollinger Band | 0.643 |
| Lower Bollinger Band | 0.516 |
| Percent B (%b) | 0.19 |
| BandWidth | 21.858 |
| MACD Line | -0.015 |
| MACD Signal Line | -0.009 |
| MACD Histogram | -0.0062 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.563 | ||||
| Resistance 3 (R3) | 0.563 | 0.557 | 0.559 | ||
| Resistance 2 (R2) | 0.557 | 0.551 | 0.556 | 0.557 | |
| Resistance 1 (R1) | 0.548 | 0.547 | 0.545 | 0.548 | 0.556 |
| Pivot Point | 0.542 | 0.542 | 0.540 | 0.541 | 0.542 |
| Support 1 (S1) | 0.533 | 0.536 | 0.530 | 0.533 | 0.524 |
| Support 2 (S2) | 0.527 | 0.532 | 0.526 | 0.523 | |
| Support 3 (S3) | 0.518 | 0.527 | 0.521 | ||
| Support 4 (S4) | 0.518 |
